sodium-taurodeoxycholate and Chondrosarcoma

sodium-taurodeoxycholate has been researched along with Chondrosarcoma* in 1 studies

Other Studies

1 other study(ies) available for sodium-taurodeoxycholate and Chondrosarcoma

ArticleYear
Incorporation of mannose 6-phosphate receptors into liposomes. Receptor topography and binding of alpha-mannosidase.
    The Biochemical journal, 1983, Aug-15, Volume: 214, Issue:2

    A receptor that binds the lysosomal enzyme alpha-mannosidase via mannose 6-phosphate moieties (mannose 6-phosphate receptor) was purified from Swarm-rat chondrosarcoma and bovine liver microsomal membranes. Receptor-reconstituted liposomes were prepared by dialysis of taurodeoxycholate-dispersed lipids with purified mannose 6-phosphate receptor. Liposomes appeared by electron microscopy as 60-120 nm unilamellar vesicles. Receptor-reconstituted liposomes retained the ability to bind alpha-mannosidase specifically. Binding was saturable with an apparent Kd of 1 nM and was competitively inhibited by mannose 6-phosphate (Ki 2mM). Liposomes containing entrapped 125I-bovine serum albumin were used to demonstrate that treatment with 0.045% taurodeoxycholate rendered liposomes permeable to macromolecules without solubilizing the membrane. Receptor orientation in the liposome membrane was established by measuring binding of ligand to intact and detergent-treated liposomes. Unlike coated vesicles, which contain cryptic mannose 6-phosphate receptors [Campbell, Fine, Squicciarini & Rome (1983) J. Biol. Chem. 258, 2526-2533], treatment of liposomes with detergent revealed no additional cryptic binding sites. In addition, treatment of liposomes with 0.75% trypsin abolished total receptor binding activity. The results suggest that the receptor is inserted with its binding site facing the outside of the liposome.

    Topics: alpha-Mannosidase; Animals; Binding Sites; Cattle; Chondrosarcoma; Liposomes; Liver; Mannosephosphates; Mannosidases; Membrane Proteins; Microscopy, Electron; Rats; Receptor, IGF Type 2; Receptors, Cell Surface; Sarcoma, Experimental; Taurodeoxycholic Acid

1983